New Lithium Capsule Study for Bipolar I
Treatments studied
Part of Mental health clinical trials.
This study compares a new lithium capsule (AL001) to a standard lithium capsule in people with Bipolar I Disorder. It aims to see how well your body absorbs each capsule and whether AL001 is safer or more tolerable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old and have Bipolar I Disorder.
- Your mood has been stable recently (no current manic or severe depression).
- You have no recent suicide attempts (within the past 2 years) and no suicidal thoughts in the past month.
- You are on a stable mood medication for at least 30 days (or untreated if stable) and willing to stay on that regimen.
- You can safely have an MRI (no metal implants, pacemaker, or other devices).
- You must avoid alcohol, poppy seeds, quinine, caffeine, and certain fruits before and during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This study tests an oral medication called icalcaprant for adults with bipolar I or II who are currently in a depressive episode. The goal is to see if it reduces symptoms and whether it's safe when taken alongside your usual mood stabilizer.
This trial tests an experimental drug called NBI-1117568 for people with bipolar I disorder who are currently having a manic or mixed episode. The goal is to see if the drug helps calm mania symptoms and is safe.
This Phase 2 study tests a medication that works on NMDA receptors to improve depression symptoms in people with bipolar I disorder. It may help if you’re currently in a bipolar depression episode and other mood treatments haven’t fully controlled it.
This study tests a new way to deliver lithium, a common treatment for bipolar disorder, using tiny gold particles. It aims to see if this method is safe and effective in laboratory models, which may lead to better treatments with fewer side effects.
This study tests an investigational drug called ALTO-100 for people with bipolar disorder who are currently experiencing depression. It aims to see if ALTO-100 can help improve depressive symptoms when added to your current mood stabilizer or antipsychotic medication.
Hear when a new Bipolar I Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.